Vaxart, Inc.
VXRT
$0.68
$0.033.91%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 726.68% | 784.27% | 479.58% | 433.43% | 288.94% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 726.68% | 784.27% | 479.58% | 433.43% | 288.94% |
| Cost of Revenue | 171.62% | 170.25% | 78.55% | 27.26% | 8.91% |
| Gross Profit | 178.40% | 37.63% | 28.31% | 34.27% | 25.10% |
| SG&A Expenses | -15.26% | -19.07% | -20.84% | -19.78% | -7.99% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 130.74% | 122.75% | 53.11% | 15.24% | 4.70% |
| Operating Income | 127.26% | 31.88% | 26.04% | 30.16% | 20.46% |
| Income Before Tax | 125.20% | 30.08% | 25.27% | 29.03% | 18.87% |
| Income Tax Expenses | 83.08% | 19.38% | 10.75% | 11.91% | -0.38% |
| Earnings from Continuing Operations | 124.39% | 29.91% | 25.13% | 28.90% | 18.82% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 124.39% | 29.91% | 25.13% | 28.90% | 18.82% |
| EBIT | 127.26% | 31.88% | 26.04% | 30.16% | 20.46% |
| EBITDA | 146.40% | 36.13% | 29.67% | 34.02% | 23.13% |
| EPS Basic | 118.32% | 46.83% | 47.19% | 49.90% | 40.40% |
| Normalized Basic EPS | 118.96% | 46.93% | 47.27% | 50.01% | 40.47% |
| EPS Diluted | 117.97% | 46.83% | 47.19% | 49.90% | 40.40% |
| Normalized Diluted EPS | 118.87% | 46.93% | 47.27% | 50.01% | 40.47% |
| Average Basic Shares Outstanding | 13.92% | 26.28% | 40.77% | 44.06% | 42.18% |
| Average Diluted Shares Outstanding | 13.96% | 26.28% | 40.77% | 44.06% | 42.18% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |